| Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features A Navarro, G Clot, C Royo, P Jares, A Hadzidimitriou, A Agathangelidis, ... Cancer research 72 (20), 5307-5316, 2012 | 284 | 2012 |
| SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma MC Vegliante, J Palomero, P Pérez-Galán, G Roué, G Castellano, ... Blood, The Journal of the American Society of Hematology 121 (12), 2175-2185, 2013 | 215 | 2013 |
| Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease C Royo, A Navarro, G Clot, I Salaverria, E Giné, P Jares, D Colomer, ... Leukemia 26 (8), 1895-1898, 2012 | 162 | 2012 |
| SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma J Palomero, MC Vegliante, ML Rodríguez, A Eguileor, G Castellano, ... Blood, The Journal of the American Society of Hematology 124 (14), 2235-2247, 2014 | 125 | 2014 |
| Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ... Annals of Oncology 29 (12), 2363-2370, 2018 | 113 | 2018 |
| SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma P Balsas, J Palomero, Á Eguileor, ML Rodríguez, MC Vegliante, ... Blood, The Journal of the American Society of Hematology 130 (4), 501-513, 2017 | 106 | 2017 |
| KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth S Raho, L Capobianco, R Malivindi, A Vozza, C Piazzolla, F De Leonardis, ... Nature Metabolism 2 (12), 1373-1381, 2020 | 73 | 2020 |
| SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6 J Palomero, MC Vegliante, A Eguileor, ML Rodriguez, P Balsas, ... Leukemia 30 (7), 1596-1599, 2016 | 61 | 2016 |
| Epigenetic activation of SOX11 in lymphoid neoplasms by histone modifications MC Vegliante, C Royo, J Palomero, I Salaverria, B Balint, ... PloS one 6 (6), e21382, 2011 | 51 | 2011 |
| microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics A Navarro, G Clot, M Prieto, C Royo, MC Vegliante, V Amador, ... Clinical Cancer Research 19 (12), 3121-3129, 2013 | 47 | 2013 |
| N‐acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages A Menga, M Favia, I Spera, MC Vegliante, R Gissi, A De Grassi, L Laera, ... EMBO reports 22 (9), e51981, 2021 | 28 | 2021 |
| The tumor microenvironment of DLBCL in the computational era G Opinto, MC Vegliante, A Negri, T Skrypets, G Loseto, SA Pileri, ... Frontiers in Oncology 10, 351, 2020 | 27 | 2020 |
| Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces S Sangaletti, F Iannelli, F Zanardi, V Cancila, P Portararo, L Botti, D Vacca, ... EBioMedicine 61, 2020 | 26 | 2020 |
| Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β S Ducheix, MC Vegliante, G Villani, N Napoli, C Sabbà, A Moschetta Cellular and molecular life sciences 73 (20), 3809-3822, 2016 | 22 | 2016 |
| Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio … R Durmo, B Donati, L Rebaud, AS Cottereau, A Ruffini, ME Nizzoli, ... Hematological oncology 40 (4), 645-657, 2022 | 21 | 2022 |
| A new ensemble method for detecting anomalies in gene expression matrices L Selicato, F Esposito, G Gargano, MC Vegliante, G Opinto, GM Zaccaria, ... Mathematics 9 (8), 882, 2021 | 20 | 2021 |
| Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2) S Modica, M Cariello, A Morgano, I Gross, MC Vegliante, S Murzilli, ... Journal of Biological Chemistry 289 (41), 28421-28432, 2014 | 16 | 2014 |
| Predictive and prognostic molecular factors in diffuse large B-cell lymphomas SA Pileri, C Tripodo, F Melle, G Motta, V Tabanelli, S Fiori, MC Vegliante, ... Cells 10 (3), 675, 2021 | 11 | 2021 |
| NR1H3 (LXRα) is associated with pro‐inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b‐cell lymphoma MC Vegliante, S Mazzara, GM Zaccaria, S De Summa, F Esposito, F Melle, ... Hematological Oncology 40 (5), 864-875, 2022 | 9 | 2022 |
| Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas V L'Imperio, G Morello, MC Vegliante, V Cancila, G Bertolazzi, S Mazzara, ... European Journal of Immunology 52 (8), 1350-1361, 2022 | 8 | 2022 |
